Thomas Gad Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

Thomas Gad is CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 181,531 shares of YMAB, which is worth approximately $1.5 Million. The most recent transaction as insider was on Sep 19, 2024, when has been sold 22,831 shares (Common Stock) at a price of $4.38 per share, resulting in proceeds of $99,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K

0% 3M change

29.2% 12M change

Total Value Held $1.5 Million

Thomas Gad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 19 2024	BUY Exercise of conversion of derivative security	$99,999 $4.38 p/Share	22,831 Added 11.17%	181,531 Common Stock
Mar 05 2024	SELL Open market or private sale	$64,116 $16.44 p/Share	3,900 Reduced 2.4%	158,700 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	22,100 Added 11.97%	162,600 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$100,000 $2.0 p/Share	50,000 Added 26.25%	140,500 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	40,500 Added 30.92%	90,500 Common Stock
Feb 01 2022	SELL Open market or private sale	$81,200 $10.15 p/Share	8,000 Reduced 13.79%	50,000 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	$16,000 $2.0 p/Share	8,000 Added 12.12%	58,000 Common Stock
Jan 18 2022	SELL Open market or private sale	$92,320 $11.54 p/Share	8,000 Reduced 13.79%	50,000 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$16,000 $2.0 p/Share	8,000 Added 12.12%	58,000 Common Stock
Nov 23 2021	SELL Open market or private sale	$853,000 $17.06 p/Share	50,000 Reduced 50.0%	50,000 Common Stock
Nov 23 2021	BUY Exercise of conversion of derivative security	$100,000 $2.0 p/Share	50,000 Added 33.33%	100,000 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$100,000 $2.0 p/Share	50,000 Added 50.0%	50,000 Common Stock
Apr 26 2021	SELL Open market or private sale	$195,720 $27.96 p/Share	7,000 Reduced 100.0%	0 Common Stock
Apr 26 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Apr 12 2021	SELL Open market or private sale	$186,270 $26.61 p/Share	7,000 Reduced 100.0%	0 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Apr 01 2021	SELL Open market or private sale	$272,340 $30.26 p/Share	9,000 Reduced 100.0%	0 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$18,000 $2.0 p/Share	9,000 Added 50.0%	9,000 Common Stock
Mar 15 2021	SELL Open market or private sale	$257,530 $36.79 p/Share	7,000 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Mar 01 2021	SELL Open market or private sale	$319,590 $35.51 p/Share	9,000 Reduced 100.0%	0 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$18,000 $2.0 p/Share	9,000 Added 50.0%	9,000 Common Stock
Feb 16 2021	SELL Open market or private sale	$329,560 $47.08 p/Share	7,000 Reduced 100.0%	0 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$14,000 $2.0 p/Share	7,000 Added 50.0%	7,000 Common Stock
Feb 01 2021	SELL Open market or private sale	$293,930 $41.99 p/Share	7,000 Reduced 100.0%	0 Common Stock

Thomas Gad

CHIEF BUSINESS OFFICER

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Value

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB

Account